tiprankstipranks
Advertisement
Advertisement

COLL Stock Latest News

Collegium Pharmaceutical Leans Into Growth After Earnings
Company AnnouncementsCollegium Pharmaceutical Leans Into Growth After Earnings
3d ago
COLL
Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook
PremiumCompany Announcements
Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook
3d ago
8K
COLL
Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52
PremiumThe Fly
Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52
3d ago
COLL
Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M
PremiumThe Fly
Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M
3d ago
COLL
Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)
PremiumRatings
Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)
25d ago
COLL
Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
PremiumRatingsCollegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
2M ago
COLL
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
Premium
Company Announcements
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
2M ago
8K
COLL
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
Premium
The Fly
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
2M ago
COLL
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
PremiumThe Fly
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
2M ago
COLL
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
PremiumCompany Announcements
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
2M ago
COLL
Collegium Reports Record 2025 Results and Reaffirms Outlook
PremiumCompany Announcements
Collegium Reports Record 2025 Results and Reaffirms Outlook
2M ago
8K
COLL
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
PremiumThe Fly
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
2M ago
COLL
Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
PremiumThe FlyCollegium Pharmaceutical sees FY26 product revenue $805M-$825M
2M ago
COLL
Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Collegium Pharmaceutical Inc. (COLL) Q4 Earnings Cheat Sheet
3M ago
COLL
Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC
Premium
The Fly
Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC
3M ago
COLL
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
PremiumThe Fly
Collegium Pharmaceutical price target raised to $58 from $55 at Truist
3M ago
COLL
Collegium Pharmaceutical management to meet with Truist
PremiumThe Fly
Collegium Pharmaceutical management to meet with Truist
3M ago
COLL
Collegium price target lowered to $56 from $58 at Barclays
PremiumThe Fly
Collegium price target lowered to $56 from $58 at Barclays
4M ago
COLL
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
PremiumThe Fly
Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright
4M ago
COLL
Collegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
PremiumRatingsCollegium Pharmaceutical: Strengthened 2026 Outlook, Balance Sheet Flexibility, and BD Upside Support Buy Rating and Higher Target
4M ago
COLL
Collegium Issues 2026 Guidance Emphasizing Jornay PM Growth
Premium
Company Announcements
Collegium Issues 2026 Guidance Emphasizing Jornay PM Growth
4M ago
8K
COLL
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
Premium
The Fly
Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M
4M ago
COLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >